Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal tract cholinergic nerves—primarily mediated by acetylcholine released from enteric neurons and extrinsic vagal fibers—are essential regulators not only of motility and secretion but also play a pivotal role in modulating mucosal immunity through mechanisms involving nicotinic receptor subtypes like α7nAChR. Their dysfunction has implications for both motility disorders and inflammatory diseases within the gut.
Activation of muscarinic and nicotinic acetylcholine receptors on smooth muscle, glandular epithelium, and immune cells to modulate GI function and inflammatory responses. Stimulation of α7nAChR on macrophages to inhibit pro-inflammatory cytokine production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal Tract Cholinergic Nerve (GI Cholinergic Nerve).